Catheter directed thrombolysis in management of early acute   thrombotic ischemia: early experience

Osama Abdou Ismail; Ahmed Saif Al-Islam Abdelfattah

doi:10.18203/2349-2902.isj20175389

Authors

Osama Abdou Ismail Department of Vascular Surgery, Sohag University, Egypt
Ahmed Saif Al-Islam Abdelfattah Department of Vascular Surgery, Sohag University, Egypt

DOI:

https://doi.org/10.18203/2349-2902.isj20175389

Keywords:

Acute thrombotic ischemia, Catheter directed thrombolysis

Abstract

Background: To assess the effectiveness of catheter directed thrombolysis in management of early acute thrombotic ischemia.

Methods: A prospective study was carried out on 18 patients (13 males, 5 females) with a mean age of 49 years (ranged from 45 - 69 years) suffered from acute thrombotic lower limb ischemia (Rutherford II- a) and submitted to catheter directed thrombolysis (CDT) using tissue plasminogen activator (TPA) between August 2015 to March 2017. The commonest thrombosed artery was superficial femoral artery (SFA). Major risk factors were diabetes and smoking (66% and 56%) respectively. The infusion method was lacing technique followed by continuous infusion.

Results: Technical success was obtained in 15 patients (83%). Complementary revascularization was performed in 5/15 patients (33.3 %) by balloon angioplasty. Limb salvage rate at 6 months was (77.7%). Failure of thrombolysis occurred in 3 limbs (16.6%); one patient treated by femoro-popliteal bypass while the other two limbs ended by amputation. Regarding complications, bleeding (local groin hematoma or minimal retroperitoneal hematoma) occurred in 3 patients (16.6 %). No major bleeding was recorded. Amputation had performed in 2 cases (11%) while mortality rate within 6 months was 16.6 %.

Conclusions: With proper patient selection, CDT should be considered the first-line treatment for patients with (Rutherford II- a) acute thrombotic limb ischemia.

Metrics

Metrics Loading ...

References

Kasirajan K, Haskal ZJ, Ouriel K. The use of mechanical thrombectomy devices in the management of acute peripheral arterial occlusive disease. J Vasc Interv Radiol. 2001;12:405-11.

Creager MA, Kaufman JA, Conte MS. Acute limb ischaemia. N Engl J Med. 2012;366:2198-206.

Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J Vascular Intervent Radiol. 2006;17(9):1383-98.

Zipser S, Kirsch CM, Lien C, Singh TM, Kang YS. Acute aortoiliac and femoral artery thrombosis complicating diabetic ketoacidosis. J Vascular Interventional Radiol. 2005;16(12):1737-9.

Acar RD, Sahin M, Kirma C. One of the most urgent vascular circumstances: Acute limb ischemia. SAGE Open Medicine. 2013;1:2050312113516110.

Patel N, Sacks D, Patel RI, Moresco KP, Ouriel K, Gray R, et al. SCVIR reporting standards for the treatment of acute limb ischemia with use of transluminal removal of arterial thrombus. J Vascular Interventional Radiol. 2001;12(5):559-70.

Patel NH, Krishnamurthy VN, Kim S, Saad WE, Ganguli S, Walker TG, et al. Quality improvement guidelines for percutaneous management of acute lower-extremity ischemia. Journal Vascular Interventional Radiol. 2013;24(1):3-15.

Morrison HL. Catheter-Directed Thrombolysis for Acute Limb Ischemia. Semin Intervent Radiol. 2006;23:258-69.

Rajan DK, Patel NH, Valji K, Cardella JF, Brown DB, Brountzos EN, et al. Quality improvement guidelines for percutaneous management of acute limb ischemia. Journal of Vascular and Interventional Radiology. 2009;20(7):208-18.

Kasirajan K. Acute ischaemia: Treatment. In: Cronenwett J, Wayne K, eds. Rutherford`s Vascular Surgery. 7th Ed. Philadelphia, PA: Saunders Elsevier, 2010:2399-2411.

Naidoo NG, Rautenbach PS, Kahn D. Acute lower extremity ischaemia. CME: SA Journal of CPD. 2013;31(6):201-5.

Jaffery Z, Thornton SN, White CJ. Acute limb ischemia. American J Med Sci. 2011;342(3):226-34.

Ouriel K, Shortell CK, DeWeese JA, Green RM, Francis CW, Azodo MV, et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vascular Surg. 1994;19(6):1021-30.

The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischaemia of the lower extremity. The STILE trial. Ann Surg. 1994;220:251-68.

Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med. 2006;338:1105-11.

Swischuk JL, Fox PF, Young K, Hussain S, Smouse B, Castañeda F, et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: results and complications. J Vascular Interventional Radiology. 2001;12(4):423-30.

Gupta R, Hennebry TA. Percutaneous isolated pharmaco‐mechanical thrombolysis‐thrombectomy system for the management of acute arterial limb ischemia: 30‐day results from a single‐center experience. Catheterization and Cardiovascular Interventions. 2012;80(4):636-43.

Knuttinen MG, Emmanuel N, Isa F, Rogers AW, Gaba RC, Bui JT, et al. Review of pharmacology and physiology in thrombolysis interventions. In Seminars Interventional Radiol. 2010;27(4):374-83.

Cinà CS, Goh RH, Chan J, Kenny B, Evans G, Rawlinson J, et al. Intraarterial catheter-directed thrombolysis: urokinase versus tissue plasminogen activator. Ann Vascular Surg. 1999;13(6):571-5.

Semba CP, Murphy TP, Bakal CW, Calis KA, Matalon TA. Thrombolytic therapy with use of alteplase (rt-PA) in peripheral arterial occlusive disease: review of the clinical literature. J Vascular Interventional Radiol. 2000;11(2):149-61.

Hanover TM, Kalbaugh CA, Gray BH, Langan EM, Taylor SM, Androes MP, et al. Safety and efficacy of reteplase for the treatment of acute arterial occlusion: complexity of underlying lesion predicts outcome. Ann Vascular Surge. 2005;19(6):817-22.

Vignali C, Cioni R, Mascalchi M, Russo R, Palla A, Lencioni R, et al. Urokinase and tissue promoter of plasminogen compared to transcatheter arterial fibrinolysis. Radiologia Medica. 1994;88(1-2):93-9.

Karnabatidis D, Spiliopoulos S, Tsetis D, Siablis D. Quality improvement guidelines for percutaneous catheter-directed intra-arterial thrombolysis and mechanical thrombectomy for acute lower-limb ischemia. Cardiovascular Interventional Radiol. 2011;34(6):1123-36.

Ward AS, Andaz SK, Bygrave S. Thrombolysis with tissue-plasminogen activator: results with a high-dose trans thrombus technique. J Vascular Surg. 1994;19(3):503-8.

Ouriel K, Welch EL, Shortell CK, Geary K, Fiore WM, Cimino C. Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vascular Surg. 1995;22(5):593-7.

Camerota A, White JV. Overview of catheter directed thrombolytic therapy for arterial and graft occlusion. In: Camerota A, editor. Thrombo- lytic therapy for peripheral vascular disease. Philadelphia: Lippincott- Raven; 2005:249-252.

Mehta RP, Johnson MS. Update on anticoagulant medications for the interventional radiologist. J Vasc Interv Radiol. 2006;17:597-612.